Akcea Therapeutics, Inc. is a wholly owned subsidiary of Ionis Pharmaceuticals, Inc., the leader in RNA therapeutics. Akcea commercializes TEGSEDI® (inotersen), which is available in the E.U. and Brazil, and WAYLIVRA® (volanesorsen), which is..
Relevance: 3.152864